会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Therapeutic agents useful for treating pain
    • 用于治疗疼痛的治疗剂
    • US07582635B2
    • 2009-09-01
    • US10739190
    • 2003-12-19
    • Qun SunLaykea TafesseSam Victory
    • Qun SunLaykea TafesseSam Victory
    • A61K31/497
    • C07D417/12A61K31/495C07D401/12C07D403/12C07D413/12
    • A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof (a “Benzoazolylpiperazine Compound”), compositions comprising a Benzoazolylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Benzoazolylpiperazine Compound are disclosed.
    • 下式的化合物:其中Ar1,A,R3,x和m如本文所公开,Ar 2是苯并噻唑基,苯并恶唑基或苯并咪唑基或其药学上可接受的盐(“苯并恶唑基哌嗪化合物”),包含苯并恶唑基哌嗪化合物 以及用于治疗或预防疼痛,UI,溃疡,IBD,IBS,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,中风,癫痫发作,瘙痒症状,精神病,认知障碍,记忆缺陷, 限制性脑功能,亨廷顿氏舞蹈病,肌萎缩性侧索硬化,痴呆,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,其中包括向有需要的动物施用有效量的苯并恶唑基哌嗪化合物。
    • 9. 发明申请
    • THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN
    • 治疗药物有用的治疗药物
    • US20100004254A1
    • 2010-01-07
    • US12499480
    • 2009-07-08
    • Qun SunLaykea TafesseSam Victory
    • Qun SunLaykea TafesseSam Victory
    • A61K31/501C07D415/00C07D403/04A61K31/497
    • C07D417/12A61K31/495C07D401/12C07D403/12C07D413/12
    • A compound of formula: wherein Ar1, A, R3, x, and m are as disclosed herein and Ar2 is a benzothiazolyl, benzooxazolyl, or benzoimidazolyl group or a pharmaceutically acceptable salt thereof (a “Benzoazolylpiperazine Compound”), compositions comprising a Benzoazolylpiperazine Compound, and methods for treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia, or depression in an animal comprising administering to an animal in need thereof an effective amount of a Benzoazolylpiperazine Compound are disclosed.
    • 下式的化合物:其中Ar1,A,R3,x和m如本文所公开,Ar 2是苯并噻唑基,苯并恶唑基或苯并咪唑基或其药学上可接受的盐(“苯并恶唑基哌嗪化合物”),包含苯并恶唑基哌嗪化合物 以及用于治疗或预防疼痛,UI,溃疡,IBD,IBS,成瘾性障碍,帕金森病,帕金森综合征,焦虑,癫痫,中风,癫痫发作,瘙痒症状,精神病,认知障碍,记忆缺陷, 限制性脑功能,亨廷顿氏舞蹈病,肌萎缩性侧索硬化,痴呆,视网膜病变,肌肉痉挛,偏头痛,呕吐,运动障碍或抑郁症,其中包括向有需要的动物施用有效量的苯并恶唑基哌嗪化合物。